The Cabinet of Ministers approved a bill on updating the strategy, which provides for the restoration of war-damaged territories and the integration of EU requirements.
The Kyiv Commercial Court will hear a lawsuit on 16 November seeking to invalidate an investment agreement for the Main Astronomical Observatory site. The investor is LLC "Freds Resorts", whose shares are held by Vladislava Molchanova's sons.
Ukrainian President explained why a new head of the Office of the Prosecutor General has not yet been appointed and responded to accusations made against him by the former head of the department.
Desnyansky District Court is hearing the prosecution's case against Vasyl Bilohura. He is accused of inflating construction material costs during the reconstruction of a gymnasium funded by Swiss grants.
Analytics show that 1,399 documents submitted by 1,012 individuals working for the SBU are hidden from public access. The record is for 2023.
The new Deputy Minister of Digital Transformation, Valeriia Koval, holds a degree in political science and has extensive experience in the digitalisation sector.
Anna Prokop described how two men and a woman surrounded a young Ukrainian in a Żabka store, insulting him and threatening to return after his shift.
A company uniting marine drone experts and investors has appeared in Bucha. Analysis of the ownership structure revealed links to the "Falkor" fund and a discussion regarding the identity of one of the beneficiaries.
A group of researchers has made a significant step in treating the consequences of stroke. According to data published in the scientific journal Nature Communications, the new drug DDL-920 allows for the complete restoration of neural connections, ensuring the return of motor functions and cognitive abilities.
To date, the study has been conducted on laboratory mice. The results showed that after the application of DDL-920, damaged neurons recover, and motor activity returns to normal. This effect offers hope for the possibility of full recovery for patients who have suffered a stroke, without residual impairments.
Scientists are already preparing to begin trials on humans. If the drug demonstrates similar efficacy and safety, it could become a revolutionary solution in stroke treatment.
Comments
No comments yet. Be the first!